# Documentation Guide for Gender Disparities Analysis

## Core Documents

1. **Methods.md**
   - Primary methodology documentation
   - Main analysis approach
   - Model specifications
   - Core results
   - Key limitations
   - Primary references

2. **Supplemental_Materials.md**
   - Extended data description
   - Detailed model specifications
   - MCMC diagnostics
   - Additional sensitivity analyses
   - Extended results
   - Code and reproducibility details

3. **Technical_Appendix.md**
   - Model selection process
   - Alternative specifications
   - Cross-validation details
   - Prior sensitivity analyses
   - Posterior predictive checks
   - Computational details

4. **Uncertainty_Analysis.md**
   - Comprehensive uncertainty quantification
   - Robustness checks
   - Validation metrics
   - Sensitivity analyses
   - Future recommendations

## Document Relationships

```
Methods.md
    ├── Supplemental_Materials.md
    │     └── Extended data details
    │     └── Complete model equations
    │     └── Detailed diagnostics
    │
    ├── Technical_Appendix.md
    │     └── Model selection evidence
    │     └── Alternative specifications
    │     └── Validation results
    │
    └── Uncertainty_Analysis.md
          └── Uncertainty sources
          └── Robustness checks
          └── Validation metrics
          └── Future directions
```

## Usage Guide

1. **For Manuscript Submission**:
   - Methods.md serves as the primary methods section
   - Other documents should be included as supplemental materials

2. **For Peer Review**:
   - Technical_Appendix.md addresses methodological questions
   - Uncertainty_Analysis.md supports robustness claims
   - Supplemental_Materials.md provides additional validation

3. **For Reproducibility**:
   - Supplemental_Materials.md includes software versions
   - Code repository structure
   - Computational environment details

4. **For Future Extensions**:
   - Uncertainty_Analysis.md provides recommendations
   - Technical_Appendix.md shows alternative approaches
   - Each document includes relevant limitations

## Key Findings Summary

1. **Participation Rates**:
   - COVID-19: 38.6% (95% CI: 22.2% - 55.4%)
   - Ebola: 38.6% (95% CI: 23.0% - 55.2%)
   - HIV: 41.7% (95% CI: 27.2% - 57.7%)

2. **Model Performance**:
   - MAE: 1.08% ± 0.23%
   - RMSE: 1.10% ± 0.24%
   - Coverage: 100.0% ± 0.0%

3. **Validation Results**:
   - Strong cross-validation performance
   - Robust to multiple sensitivity checks
   - Well-calibrated uncertainty estimates

4. **Future Directions**:
   - Additional data collection needs
   - Methodological extensions
   - Validation approaches

